Bone-targeted Nanoparticles Could Improve Chemotherapy’s Delivery to Bone Metastasis

Bone-targeted Nanoparticles Could Improve Chemotherapy’s Delivery to Bone Metastasis
Researchers at the University of North Texas Health Science Center are developing a new strategy called bone-targeted nanoparticles to improve the delivery of the chemotherapy drug Jevtana (cabazitaxel) to bone metastasis in prostate cancer patients. The preclinical research, titled “Efficient Bone Microenvironment Nano-Targeting for Improved Therapy for Bone Metastatic Prostate Cancer,” was presented during the 2017

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *